119 related articles for article (PubMed ID: 25412552)
21. FRAX and the assessment of the risk of developing a fragility fracture.
Middleton RG; Shabani F; Uzoigwe CE; Shoaib A; Moqsith M; Venkatesan M
J Bone Joint Surg Br; 2012 Oct; 94(10):1313-20. PubMed ID: 23015554
[TBL] [Abstract][Full Text] [Related]
22. Bone mineral density thresholds for pharmacological intervention to prevent fractures.
Siris ES; Chen YT; Abbott TA; Barrett-Connor E; Miller PD; Wehren LE; Berger ML
Arch Intern Med; 2004 May; 164(10):1108-12. PubMed ID: 15159268
[TBL] [Abstract][Full Text] [Related]
23. Use of clinical risk factors in elderly women with low bone mineral density to identify women at higher risk of hip fracture: The EPIDOS prospective study.
Dargent-Molina P; Douchin MN; Cormier C; Meunier PJ; Bréart G;
Osteoporos Int; 2002 Jul; 13(7):593-9. PubMed ID: 12111021
[TBL] [Abstract][Full Text] [Related]
24. Comparison of different screening tools (FRAX®, OST, ORAI, OSIRIS, SCORE and age alone) to identify women with increased risk of fracture. A population-based prospective study.
Rubin KH; Abrahamsen B; Friis-Holmberg T; Hjelmborg JV; Bech M; Hermann AP; Barkmann R; Glüer CC; Brixen K
Bone; 2013 Sep; 56(1):16-22. PubMed ID: 23669650
[TBL] [Abstract][Full Text] [Related]
25. [Ten-year fracture risk by FRAX(®) of women with osteoporosis attending osteoporosis care in Hungary].
Péntek M; Gulácsi L; Tóth E; Baji P; Brodszky V; Horváth C
Orv Hetil; 2016 Jan; 157(4):146-53. PubMed ID: 26772827
[TBL] [Abstract][Full Text] [Related]
26. The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study.
Tuzun S; Eskiyurt N; Akarirmak U; Saridogan M; Johansson H; McCloskey E; Kanis JA;
Arch Osteoporos; 2012; 7():229-35. PubMed ID: 23060308
[TBL] [Abstract][Full Text] [Related]
27. The relationship between the OSTEODENT index and hip fracture risk assessment using FRAX.
Horner K; Allen P; Graham J; Jacobs R; Boonen S; Pavitt S; Nackaerts O; Marjanovic E; Adams JE; Karayianni K; Lindh C; van der Stelt P; Devlin H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Aug; 110(2):243-9. PubMed ID: 20659701
[TBL] [Abstract][Full Text] [Related]
28. FRAX 10-yr Fracture Risk in Rheumatoid Arthritis-Assessments With and Without Bone Mineral Density May Lead to Very Different Results in the Individual Patient.
Elde KD; Madsen OR
J Clin Densitom; 2019; 22(1):31-38. PubMed ID: 30497868
[TBL] [Abstract][Full Text] [Related]
29. Hip fracture incidence from 1981 to 2009 in the Czech Republic as a basis of the country-specific FRAX model.
Stepan JJ; Vaculik J; Pavelka K; Zofka J; Johansson H; Kanis JA
Calcif Tissue Int; 2012 May; 90(5):365-72. PubMed ID: 22399225
[TBL] [Abstract][Full Text] [Related]
30. FRAX and its applications in health economics--cost-effectiveness and intervention thresholds using bazedoxifene in a Swedish setting as an example.
Ström O; Borgström F; Kleman M; McCloskey E; Odén A; Johansson H; Kanis JA
Bone; 2010 Aug; 47(2):430-7. PubMed ID: 20493983
[TBL] [Abstract][Full Text] [Related]
31. Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: the Fracture Intervention Trial.
Donaldson MG; Palermo L; Ensrud KE; Hochberg MC; Schousboe JT; Cummings SR
J Bone Miner Res; 2012 Aug; 27(8):1804-10. PubMed ID: 22492479
[TBL] [Abstract][Full Text] [Related]
32. Validation of the FRAX predictive model for major osteoporotic fracture in a historical cohort of Spanish women.
Tebé Cordomí C; Del Río LM; Di Gregorio S; Casas L; Estrada MD; Kotzeva A; Espallargues M
J Clin Densitom; 2013; 16(2):231-7. PubMed ID: 22748778
[TBL] [Abstract][Full Text] [Related]
33. Ten-year fracture risk in the assessment of osteoporosis management efficacy in postmenopausal women: a pilot study.
Pluskiewicz W; Drozdzowska B; Adamczyk P
Climacteric; 2013 Feb; 16(1):117-26. PubMed ID: 22335356
[TBL] [Abstract][Full Text] [Related]
34. Low self-awareness of osteoporosis and fracture risk among postmenopausal women.
Langer FW; da Silveira Codevilla AA; Bringhenti R; Dal Osto LC; Campos TR; Martins TT; Barin AE; Rigo PH; Boufleuer ND; Santinon SF; Kipper K; Rodrigues J; Premaor MO
Arch Osteoporos; 2016 Dec; 11(1):27. PubMed ID: 27503622
[TBL] [Abstract][Full Text] [Related]
35. [The fracture risk assessment tool (FRAXTM), where are we in Tunisia?].
Zrour-Hassen S; Jguirim M; Guezguez M; Mnif H; Younes M; Bejia I; Touzi M; Abid A; Essabah H; Bergaoui N
Tunis Med; 2011 Feb; 89(2):136-41. PubMed ID: 21308620
[TBL] [Abstract][Full Text] [Related]
36. Validity of bone mineral density and WHO fracture risk assessment thresholds in hip fractures.
Shahla A
Arch Iran Med; 2011 Sep; 14(5):352-4. PubMed ID: 21888461
[TBL] [Abstract][Full Text] [Related]
37. Osteoporotic fracture risk evaluation. Options when central densitometry is not available.
Garduño-García Jde J; Pérez-Espejel I; Huitrón-Bravo G; Romero-Figueroa Mdel S
Rev Med Inst Mex Seguro Soc; 2014; 52(6):674-9. PubMed ID: 25354062
[TBL] [Abstract][Full Text] [Related]
38. [Usefulness of FRAX and future issues in women's health].
Hashimoto K; Ishitani K; Ohta H
Clin Calcium; 2009 Dec; 19(12):1742-8. PubMed ID: 19949265
[TBL] [Abstract][Full Text] [Related]
39. Frequency of FRAX risk factors in osteopenic postmenopausal women with and without history of fragility fracture.
Baró F; Cano A; Sánchez Borrego R; Ferrer J; González Rodríguez SP; Neyro JL; Rodriguez Bueno E; Sancho C; Inaraja V; Fernández C; Corral C;
Menopause; 2012 Nov; 19(11):1193-9. PubMed ID: 22948137
[TBL] [Abstract][Full Text] [Related]
40. Incidence of hip fracture in Barranquilla, Colombia, and the development of a Colombian FRAX model.
Jaller-Raad JJ; Jaller-Char JJ; Lechuga-Ortiz JA; Navarro-Lechuga E; Johansson H; Kanis JA
Calcif Tissue Int; 2013 Jul; 93(1):15-22. PubMed ID: 23471427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
